2018 annual financial data
Innate Pharma S.A. - American Depositary Shares 2018 Net margin
Innate Pharma S.A. - American Depositary Shares 2018 net margin with verified r…
Direct answer
Net margin was 3.82%.
Operating income was 5,146,000 EUR and net income was 3,049,000 EUR.
Operating cash flow was -32,531,000 EUR.
Get free Innate Pharma S.A. - American Depositary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 79,892,000 EUR
- Operating income
- 5,146,000 EUR
- Net income
- 3,049,000 EUR
- Operating cash flow
- -32,531,000 EUR
Explore related company data
View all 2018 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Innate Pharma S.A. - American Depositary Shares financial years